John Oates
Co-Founder and CEO @ Recombination Therapeutics
Philadelphia, United States
John Oates is a startup investor at Recombination Therapeutics in Philadelphia. John Oates is the Co-Founder and CEO of Recombination Therapeutics. He previously worked at United BioSource Corporation as a General Manager of Biotechnology Solutions. John Oates attended Alfred Lerner College of Business & Economics at the University of Delaware.
Last updated:
For AI agents: llms.txt
About Recombination Therapeutics
Recombination Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
John Oates
Co-Founder and CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
